Pharmacological control of the mevalonate pathway: Effect on arterial smooth muscle cell proliferation

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 3, 1997, Pages 1144-1153

  Raiteri, Marco ^a   Arnaboldi, Lorenzo ^a   Mcgeady, Paul ^c   Gelb, Michael H ^b   Verri, Daniela ^a   Tagliabue, Carlo ^a   Quarato, Pierangelo ^a   Ferraboschi, Patrizia ^a   Santaniello, Enzo ^a   Paoletti, Rodolfo ^a   Fumagalli, Remo ^a   Corsini, Alberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CLARK ATLANTA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [(3,3' BITHIOPHEN 5 YL)METHOXY] N (6,6 DIMETHYL 2 HEPTEN 4 YNYL) N ETHYLBENZYLAMINE; 6 [2 (4' FLUORO 3,3',5 TRIMETHYL 2 BIPHENYLYL)VINYL] 4 HYDROXY 2 OXOTETRAHYDROPYRAN; BENZODIAZEPINE; DECARBOXYLASE INHIBITOR; DOLICHOL; FARNESOL; FLUINDOSTATIN; GERANIOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPRENOID; MEVALONIC ACID; PRAVASTATIN; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PYROPHOSPHATE; SIMVASTATIN; SQUALENE; SQUALENE MONOOXYGENASE; SQUALENE SYNTHASE INHIBITOR; UBIQUINONE; ZARAGOZIC ACID A;

ANIMAL CELL; AORTA MEDIA; ARTERY MUSCLE; ARTICLE; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; MALE; NONHUMAN; PRENYLATION; PRIORITY JOURNAL; RAT;

ANIMALS; AORTA; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; LOVASTATIN; MALE; MEVALONIC ACID; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; SIMVASTATIN;

EID: 15644376974     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (98)

1. ARMSTRONG, S. A., HANNAH, V. C., GOLDSTEIN, J. L. AND BROWN, M. S.: CAAX geranylgeranyl transferase transfers farnesyl as efficiently as geranylgeranyl to RhoB. J. Biol. Chem. 270: 7864-7868, 1995.
2. BAXTER, A., FITZGERALD, B. J., HUTSON, J. L., MCCARTHY, A. D., MOTTERAM, J. M., Ross, B. C., SAPRA, M., SNOWDEN, M. A., WATSON, N. S., WILLIAMS, R. J. AND WRIGHT, C.: Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo. J. Biol. Chem. 267: 11705-11708, 1992.
3. BISHOP, W. R., BOND, R., PETRIN, J., WANG, L., PATTON, R., DOLL, R., NJORGE, G., CATINO, J., SCHWARTZ, J., WINDSOR, W., SYTO, R., CARR, D., JAMES, L. AND KIRSCHMEIER, P.: Novel tricyclic inhibitors of farnesyl protein transferase. Biochemical characterization and inhibition of Ras modification in transfected COS cells. J. Biol. Chem. 270: 30611-30618, 1995.
4. BOGUSKI, M. S. AND MCCORMICK, F.: Proteins regulating Ras and its relatives. Nature 366: 643-654, 1993.
5. BRADFUTE, D. L., SILVA, C. J. AND SIMONI, R. D.: Squalene synthase-deficient mutant of Chinese hamster ovary cells. J. Biol. Chem. 267: 18308-18314, 1992.
6. BROWN, M. S., FAUST, J. R., GOLDSTEIN, J. L., KANEKO, I. AND ENDO, A.: Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. J. Biol. Chem. 253: 1121-1128, 1978.
7. CARLBERG, M., HJERTMAN, M., WEJDE, J. AND LARSSON, O.: Mevalonate is essential for growth activation of human fibroblasts: evidence for a critical role of protein glycosylation in the prereplicative period. Exp. Cell Res. 212: 359-366, 1994.
8. CASEY, P. J., SOLSKY, P. A., DER, C. J. AND BUSS, J. E.: p21ras is modified by a farnesyl isoprenoid. Proc. Natl. Acad. Sci. U.S.A. 86: 8323-8327, 1989.
9. CASEY, P. J.: Biochemistry of protein prenylation. J. Lipid Res. 33: 1731-1740, 1992.
10. CASEY, P. J., MOOMAW, J. F., ZHANG, F. L., HIGGINS, J. B. AND THISSEN, J. A.: Prenylation and G protein signaling. In Recent Progress in Hormone Research, vol 49, pp 215-233. ed by C Wayne Bardin, Academic Press Inc., San Diego, CA, 1994.
11. CASEY, P. J. AND SEABRA, M. C.: Protein prenyltransferases J. Biol. Chem. 271: 5289-5292, 1996.
12. CHEN, H. W.: Role of cholesterol metabolism in cell growth. Fed. Proc. 43: 126-130, 1984.
13. CHEN, W. J., ANDRES, D. A., GOLDSTEIN, J. L., RUSSELL, D. W. AND BROWN, M. S.: cDNA cloning and expression of the peptide-binding beta subunit of rat p21ras farnesyltransferase, the counterpart of yeast DPR1/RAM1. Cell 66: 327-334, 1991.
14. CORSINI, A., BERNINI, F., CIGHETTI, G., SOMA, M. R., GALLI, G. AND FUMAGALLI, R.: Lipophilic β-adrenoceptor antagonists stimulate cholesterol biosynthesis in human skin fibroblasts. Biochem. Pharmacol. 36: 1901-1906, 1987.
15. CORSINI, A., RAITERI, M., SOMA, M. R., FUMAGALLI, R. AND PAOLETTI, R.: Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytes. Pharmacol. Res. 23: 173-180, 1991.
16. CORSINI, A., MAZZOTTI, M., RAITERI, M., SOMA, M. R., GABBIANI, G., FUMAGALLI, R. AND PAOLETTI, R.: Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis 101: 117-125, 1993.
17. CORSINI, A., RAITERI, M., SOMA, M. R., BERNINI, F., FUMAGALLI, R. AND PAOLETTI, R.: Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Am. J. Cardiol. 76: 21A-28A, 1995a.
18. CORSINI, A., VERRI, D., RAITERI, M., QUARATO, P., PAOLETTI, R. AND FUMAGALLI, R.: Effect of 26-aminocholesterol, 27-hydroxycholesterol and 25-hydroxycholesterol on proliferation and cholesterol homeostasis in arterial myocytes. Arterioscler. Thromb. Vase. Biol. 15: 420-428, 1995b.
19. CORSINI, A., ARNABOLDI, L., RAITERI, M., QUARATO, P., FAGGIOTTO, A., PAOLETTI, R. AND FUMAGALLI, R.: Effect of the new HMG-CoA reductase inhibitor cerivastatin (BAY W 6228) on migration, proliferation, and cholesterol synthesis in arterial myocytes. Pharmacol. Res. 33: 55-61, 1996.
20. Cox, A. D., HISAKA, M. M., BUSS, J. E. AND DER, C. J.: Specific isoprenoid modification is required for the function of normal but not oncogenic ras protein. Mol. Cell. Biol. 12: 2606-2615, 1992.
21. CRICK, D. C., WAECHER, C. J. AND ANDRES, D. A.: Utilization of geranylgeraniol for protein isoprenylation in C6 glial cells. Biochem. Biophys. Res. Commun. 205: 955-961, 1994.
22. CRICK, D. C., ANDRES, D. A. AND WAECHTER, C. J.: Farnesol is utilized for protein isoprenylation and the biosynthesis of cholesterol in mammalian cells. Biochem. Biophys. Res. Commun. 211: 590-599, 1995.
23. CUTHBERT, J. A. AND LIPSKY, P. E.: Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation. J. Biol. Chem. 265: 18568-18575, 1990.
24. CUTHBERT, J. A. AND LIPSKY, P. E.: Negative regulation of cell proliferation by mevalonate or one of the mevalonate phosphates. J. Biol. Chem. 266: 17966-17971, 1991.
25. DANESI, R., MCLELLAN, C. A. AND MYERS, C. E.: Specific labeling of isoprenylated proteins: application to study inhibitors of the post-translational farnesylation and geranylgeranylation. Biochem. Biophys. Res. Commun. 206: 637-643, 1995.
26. DECLUE, J. E., VASS, W. C., PAPAGEORGE, A. G., LOWY, D. R. AND WILLUMSEN, B. M.: Inhibition of cell growth by lovastatin is independent of ras function. Cancer Res. 51: 712-717, 1991.
27. DHE-PAGANON, S., MAGRATH, J. AND ABELES, R. H.: Mechanism of mevalonate pyrophosphate decarboxylase: evidence for a carbocationic transition state. Biochemistry 33: 13355-13362, 1994.
28. DOYLE, J. W., WARD-BAILEY, P. F. AND KANDUTSCH, A. A.: Effects of growth factors on cell cycle arrest in dolichyl phosphate-depleted cultures. J. Cell Physiol. 155: 171-178, 1993.
29. DOYLE, J. W. AND KANDUTSCH, A. A.: Requirement for mevalonate in cycling cells: Quantitative and temporal aspects. J. Cell. Physiol. 137: 133-140, 1988.
30. 2: potent inhibitors of squalene synthase and of Ras farnesyl-protein transferase. J. Nat. Prod. 56: 1923-1929, 1993.
31. FAIRBANKS, K. P., WITTE, L. AND GOODMAN, D. S.: Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor. J. Biol. Chem. 259: 1546-1551, 1984.
32. FARNSWORTH, C. C., WOLDA, S. L., GELB, M. H. AND GLOMSET, J. A.: Human lamin B contains a farnesylated cysteine residue. J. Biol. Chem. 264: 20422-20429, 1989.
33. FARNSWORTH, C. C., GELB, M. H. AND GLOMSET, J. A.: Identification of geranylgeranyl-modified proteins in HeLa cells. Science 247: 320-322, 1990.
34. FAUST, J. R. AND DICE, J. F.: Evidence for isopentenyladenosine modification on a cell cycle-regulated protein. J. Biol. Chem. 266: 9961-9970, 1991.
35. FISHER, R. A. AND YATES, F.: Statistical Tables for Biological, Agricultural and Medical Research, Oliver and Boyd, Edinburgh, 1953.
36. GIBBS, J. B., POMPLIANO, D. L., MOSSER, S. D., RANDS, E., LINGHAM, R. B., SINGH, S. B., SCOLNIK, E. M., KOHL, N. E. AND OLIFF, A.: Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo. J. Biol. Chem. 268: 7617-7620, 1993.
37. GIBBS, J. B., OLIFF, A. AND KOHL, N. E.: Farnesyltransferase inhibitors: ras research yields a potential cancer therapeutic. Cell 77: 175-178, 1994.
38. GLOMSET, J. A., GELB, M. H. AND FARNSWORTH, C. C.: Prenyl proteins in eukaryotic cells: a new type of membrane anchor. Trends Biochem. Sci. 15: 139-142, 1990.
39. GLOMSET, J. A. AND FARNSWORTH, C. C.: Role of protein modification reactions in programming interactions between ras-related GTPases and cell membranes. Annu. Rev. Cell Biol. 10: 181-205, 1994.
40. GOLDSTEIN, J. L. AND BROWN, M. S.: Regulation of the mevalonate pathway. Nature 343: 425-430, 1990.
41. GRUNLER, J., ERICSSON, J. AND DALLNER, G.: Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins. Biochim. Biophys. Acta 1212: 259-277, 1994.
42. HABENICHT, A. J. R., GLOMSET, J. A. AND ROSS, R.: Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J. Biol. Chem. 255: 5134-5140, 1980.
43. HANCOCK, J. F.: Anti-ras drugs come of age. Curr. Biol. 3: 770-772, 1993.
44. HANCOCK, J. T., MAGEE, A. I., CHILDS, J. E. AND MARSHALL, C. J.: All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57: 1167-1177, 1989.
45. HEIM, M. H.: The Jak-STAT pathway: Specific signal transduction from the cell membrane to the nucleus. Eur. J. Clin. Invest. 26: 1-12, 1996.
46. HORIE, M., TSUCHIYA, Y., HAYASHI, M., IIDA, Y., IWASAWA, Y., NAGATA, Y., SAWASAKI, Y., FUKUZUMI, H., KITANI, K. AND KAMEI, T.: NB-598: A potent competitive inhibitor of squalene epoxidase. J. Biol. Chem. 265: 18075-18078, 1990.
47. INDOLFI, C., AVVEDIMENTO, E. V., RAPACCIUOLO, A., DI LORENZO, E., ESPOSITO, G., STABILE, E., FELICIELLO, A., MELE, E., GIULIANO, P., CONDORELLI, G. AND CHIARIELLO, M.: Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Med. 1: 541-545, 1995.
48. βγ interactions with PH domains and Ras-MAPK signaling pathways. Trends Biochem. Sci. 20: 151-156, 1995.
49. JAKOBISIAK, M., BRUNO, S., SKIERSKI, J. S. AND DARZYNKIEWICZ, Z.: Cell cyclespecific effects of lovastatin. Proc. Natl. Acad. Sci. U.S.A. 88: 3628-3632, 1991.
50. JAMES, G. L., GOLDSTEIN, J. L., BROWN, M. S., RAWSON, T. E., SOMERS, T. C., MCDOWELL, R. S., CROWLEY, C. W., LUCAS, B. K., LEVINSON, A. D. AND MARSTERS, J. C., JR.: Benzodiazepine peptidomimetics: Potent inhibitors of ras farnesylation in animal cells. Science 260: 1937-1942, 1993.
51. JAMES, G. L., BROWN, M. S., COBB, M. H. AND GOLDSTEIN, J. L.: Benzodiazepine peptidomimetic BZA-5B interrupts the MAP kinase activation pathway in H-ras-transformed rat-1 cells, but not in untransformed cells. J. Biol. Chem. 269: 27705-27714, 1994.
52. JAMES, G. L., GOLDSTEIN, J. L. AND BROWN, M. S.: Polylysine and CVIM sequences of K-RasB dictase specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro. J. Biol. Chem. 270: 6221-6226, 1995.
53. v12 proteins to farnesyltransferase inhibitors in Rat1 cells. Proc. Natl. Acad. Sci. U.S.A. 93: 4454-4458, 1996.
54. 1 to multiple cell cycles by lovastatin. Cancer Res. 51: 3602-3609, 1991.
55. KOHL, N. E., OMER, C. A., CONNER, M. W., ANTHONY, N. J., DAVIDE, J. P., DESOLMS, S. J., GIULIANI, E. A., GOMEZ, R. P., GRAHAM, S. L., HAMILTON, K., HANDT, L. K., HARTMAN, G. D., KOBLAN, K. S., KRAL, A. M., MILLER, P. J., MOSSER, S. D., O'NEILL, T. J., RANDS, E., SCHABER, M. D., GIBBS, J. B. AND OLIFF, A.: Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nature Med. 1: 792-797, 1995.
56. 1-progression in Swiss 3T3-cells. J. Cell. Physiol. 129: 94-102, 1986.
57. LERNER, E. C., QIAN, Y., HAMILTON, A. D. AND SEBTI, S. M.: Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyl-transferase I inhibitor. J. Biol. Chem. 270: 26770-26773, 1995.
58. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
59. LOWY, D. R. AND WILLUMSEN, B. M.: Function and regulation of ras. Annu. Rev. Biochem. 62: 851-891, 1993.
60. LOWY, D. R. AND WILLUMSEN, B. M.: Rational cancer therapy. Nature Med. 1: 747-748. 1995.
61. LUDWIG, S. AND RAPP, U. R.: Cascading towards vascular disorders gene therapy. Nature Med. 1: 513-515, 1995.
62. MALTESE, W. A.: Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J. 4: 3319-3328, 1990.
63. MARSHALL, M. S.: Ras target proteins in eukaryotic cells. FASEB J. 9: 1311-1318, 1995.
64. MITTELMAN, A., EVANS, J. T. AND CHEDA, G. B.: Cytokinins as chemotherapeutic agents. Ann. NY Acad. Sci. 255: 225-234, 1975.
65. MUMBY, S. M., CASEY, P. J., GILMAN, A. G., GUTOWSKI, S. AND STERNWEIS, P. C. G.: protein γ subunits contain a 20-carbon isoprenoid. Proc. Natl. Acad. Sci. U.S.A. 87: 5873-5877, 1990.
66. MUNRO, E., PATEL, M., CHAN, P., BETTERIDGE, L., CLUNN, G., GALLAGHER, K., HUGHES, A., SCHACHTER, M., WOLFE, G. AND SEVER, P.: Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis. Eur. J. Clin. Invest. 24: 766-772, 1994.
67. NAVE, J.-F., D'ORCHYMOND, H., DUCEP, J.-B., PIRIOU, F. AND JUNG, M. J.: Mechanism of the inhibition of cholesterol biosynthesis by 6-fluoromevalonate. Biochem. J. 227: 247-254, 1985.
68. O'DONNELL, M. P., KASISKE, B. L., KIM, Y., ATLURU, D. AND KEANE, W. F.: Lovastatin inhibits proliferation of rat mesangial cells. J. Clin. Invest. 91: 83-87, 1993.
69. 1. Science 269: 1270-1272, 1995.
70. PARKER, R., CLARK, R. W., SIT, S., LANIER, T. L., GROSSO, R. A. AND WRIGHT, J.: Selective inhibition of cholesterol synthesis in liver versus extrahepatic tissues by HMG-CoA reductase inhibitors. J. Lipid Res. 31: 1271-1282, 1990.
71. PERKINS, J. L., LEDIN, J. F. AND STUBBS, J. D.: Linkage of the isoprenoid biosynthesis pathway with induction of DNA synthesis in mouse lymphocytes: effects of compactin on mitogen-induced lymphocytes in serum-free medium. Biochim. Biophys. Acta 711: 83-89, 1982.
72. PUMIGLIA, K. M., LEVINE, H., HASKE, T., HABIB, T., JOVE, R. AND DECKER, S. J.: A direct interaction between G-protein βγ subunits and the Raf-1 protein kinase. J. Biol. Chem. 270: 14251-14254, 1995.
73. QUARCK, R., BRYCKAERT, M., MAGNIER, C., CORVAZIER, E., BREDOUX, R., DE GUNZBURG, J., FONTENAY, M., TOBELEM, G. AND ENOUF, J.: Evidence of Rap1 in vascular smooth muscle cells. Regulation of their expression by platelet-derived growth factor BB. FEBS Lett. 342: 159-164, 1994.
74. QUESNEY-HUNEEUS, V., WILEY, M. H. AND SIPERSTEIN, M.: Isopentenyladenosine as a mediator of mevalonate-regulated DNA replication. Proc. Natl. Acad. Sci. U.S.A. 77: 5842-5846, 1980.
75. QUESNEY-HUNEEUS, V., GALICK, H. A., SIPERSTEIN, M. D., ERICKSON, S. K., SPENCER, T. A. AND NELSON, J. A.: The dual role of mevalonate in the cell cycle. J. Biol. Chem. 258: 378-385, 1983.
76. QUISTAD, G. B., CERF, D. C., SCHOOLEY, D. A. AND STAAL, G. B.: Fluoromevalonate acts as an inhibitor of insect juvenile hormone biosynthesis. Nature 289: 176-177, 1981.
77. REARDON, J. E. AND ABELES, R. H.: Inhibition of cholesterol biosynthesis by fluorinated mevalonate analogues. Biochemistry 26: 4717-4722, 1987.
78. REISS, Y., GOLDSTEIN, J. L., SEABRA, M. C., CASEY, P. J. AND BROWN, M. S.: Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides. Cell 62: 81-88, 1990.
79. Ross, R.: The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J. Cell Biol. 50: 172-186, 1971.
80. Ross, R.: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
81. SADHU, D. N. AND RAMOS, K. S.: Cyclic AMP inhibits c-Ha-ras protooncogene expression and DNA synthesis in rat aortic smooth muscle cells. Experientia 49: 567-570, 1993.
82. SAWAMURA, M., LI, N., NARA, Y. AND YAMORI, Y.: Proliferative effect of mevalonate metabolites other than isoprenoids on cultured vascular smooth muscle cells. Clin. Exp. Pharmacol. Physiol. 20: 509-514, 1993.
83. SEPP-LORENZINO, L., RAO, S. AND COLEMAN, P. S.: Cell-cycle-dependent, differential prenylation of proteins. Eur. J. Biochem. 200: 579-590, 1991.
84. SEPP-LORENZINO, L., MA, Z., RANDS, E., KOHL, N. E., GIBBS, J. B., OLIFF. A. AND ROSEN, N.: A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines. Cancer Res. 55: 5302-5309, 1995.
85. SINENSKY, M. AND LOGEL, J.: Defective macromolecule biosynthesis and cell-cycle progression in a mammalian-cell starved for mevalonate. Proc. Natl. Acad. Sci. U.S.A. 82: 3257-3261, 1985.
86. SINENSKY, M. AND LUTZ, R. J.: The prenylation of proteins. Bioessays 14: 25-31, 1992.
87. SKALLI, O., ROPRAZ, P., TREZCIAK, A., BENZONANA, G., GILLESSEN, D. AND GABBIANI, G.: A monoclonal antibody against alfa-smooth muscle actin: a new probe for smooth muscle differentiation. J. Cell Biol. 103: 2787-2796, 1986.
88. TAMANOI, F.: Inhibitors of ras farnesyltransferases. Trends Biochem. Sci. 18: 349-353, 1993.
89. TRUEBLOOD, C. E., OHYA, Y. AND RINE, J.: Genetic evidence for in vivo cross-specificity of the CAAX box protein prenyltransferase farnesyltransferase and geranylgeranyltransferase-I in Saccharomyces cumvisia. Mol. Cell. Biol. 13: 4260-275, 1993.
90. H p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs. Mol. Cell. Biol. 4: 1647-1652, 1984.
91. VINCENT, S., JEANTEUR, P. AND FORT, P.: Growth-regulated expression of rhoG, a new member of the ras homolog gene family. Mol. Cell. Biol. 12: 3138-3148, 1992.
92. VOJTEK, A. B. AND COOPER, J. A.: Rho family members: activators of MAP kinase cascades. Cell 82: 527-529, 1995.
93. WEJDE, J., CARLBERG, M., HJERTMAN, M. AND LARSSON, O.: Isoprenoid regulation of cell growth: identification of mevalonate-labelled compounds inducing DNA synthesis in human breast cancer cells depleted of serum and mevalonate. J. Cell. Physiol. 155: 539-548, 1993.
94. YAMANE, H. K., FARNSWORTH, C. C., XIE, H. Y., HOWALD, W., FUNG, B. K., CLARKE, S., GELB, M. H. AND GLOMSET, J. A. BRAIN G.: protein γ subunits contain an all-trans-geranylgeranylcysteine methyl ester at their carboxyl termini. Proc. Natl. Acad. Sci. U.S.A. 87: 5868-5872, 1990.
95. YAMANE, H. K., FARNSWORTH, C. C., XIE, H. Y., EVANS, T., HOWALD, W. N., GELB, M. H., GLOMSET, J. A., CLARKE, S. AND FUNG, B. K.: Membrane-binding domain of the small G protein G25K contains an S-(all-trans-geranylgeranyl)cysteine methyl ester at its carboxyl terminus. Proc. Natl. Acad. Sci. U.S.A. 88: 286-290, 1991.
96. YOKOYAMA, K., MCGEADY, P. AND GELB, M. H.: Mammalian protein geranylgeranyltransferase-I: Substrate specificity, kinetic mechanism, metal requirements, and affinity labeling. Biochemistry 34: 1344-1354, 1995.
97. YOKOYAMA, K. AND GELB, M. H.: Purification of a mammalian protein geranylgeranyltranferase. J. Biol. Chem. 268: 4055-4060, 1993.
98. ZHANG, F. L., DIEHL, R. E., KOHL, N. E., GIBBS, J. B., GIROS, B., CASEY, P. AND OMERS, C. A.: cDNA cloning and expression of rat and human protein geranylgeranyltransferase type-I. J. Biol. Chem. 269: 3175-3180, 1994.